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bjectives Our aim was to investigate in-hospital outcomes of percutaneous coronary intervention
PCI) of chronic total occlusion (CTO) using contemporary techniques.
ackground Despite its increasing popularity and technical complexity, clinical outcomes of PCI for
TO using contemporary techniques have not been adequately evaluated.
ethods The J-CTO registry (multicenter CTO registry in Japan) is a large scale, multicenter registry
nrolling consecutive patients undergoing PCI for CTO from 12 Japanese centers. In-hospital clinical
utcomes were evaluated in 498 patients with 528 CTO lesions.
esults Multiple wiring strategies were frequently attempted (parallel wiring 31% and retrograde ap-
roach 25%) with relatively long guidewire manipulation time (median 30 min). Utilizing these complex
trategies, high procedural success rates (88.6% in the ﬁrst attempt cases and 68.5% in the retry cases)
ere accomplished. In-hospital adverse event rates were strikingly low (cardiac death 0.2%, Q-wave myo-
ardial infarction 0.2%, and stroke 0%). Potential disadvantages of these procedures, including a large
mount of contrast volume (median 293 ml) and long ﬂuoroscopic time (median 45 min), were not asso-
iated with serious clinical sequelae (contrast induced nephropathy 1.2% and radiation dermatitis 0%).
lthough coronary perforations were documented frequently by angiography (antegrade 7.2% and retro-
rade 13.6%), clinically signiﬁcant perforation resulting in cardiac tamponade was rare (0.4%).
onclusions Most CTO lesions can be safely and successfully treated with PCI utilizing contemporary ad-
anced techniques. Invasiveness and potential risks of these strategies, which have been the greatest concerns
f CTO treatment, may be acceptable in the majority of cases considering the actual incidences of related ad-
erse events and the procedural success rates. (J Am Coll Cardiol Intv 2010;3:143–51) © 2010 by the
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144ercutaneous coronary intervention (PCI) of chronic total
cclusion (CTO) lesions represents a great technical chal-
enge. Because of low procedural success rate (1,2), high
estenosis rate (3,4), and high incidence of adverse events
5–7) documented in the early reports of PCI, a large
opulation of patients with CTOs have been managed
edically, and such lesions have been the most common
eason for referral to bypass surgery rather than PCI (8).
owever, the benefits of recanalization of CTOs were
radually proven with outcome of improved left ventricular
unction (9,10) and prolonged survival (5,6). Since the
ntroduction of drug-eluting stents (DES), there has been a
triking reduction in restenosis rates (11–13). Consequently,
boost in motivation and interest has taken place for this
last frontier” of PCI in the current clinical arena.
See page 152
Recently, techniques for PCI of
CTO have dramatically changed.
The parallel wiring technique and
the retrograde approach have been
introduced. These techniques may
further improve success rate yet,
simultaneously, they potentially
prolong procedural time and en-
hance the risk of complications.
Such effects have not been sys-
temically evaluated. Therefore,
this study sought to investigate
the in-hospital outcomes using
the largest available datasets of
an ongoing J-CTO (multicenter
CTO registry in Japan). The
analysis aimed to elucidate the
“net” clinical impacts of contem-
porary PCI technique with in-
epth assessments of potential disadvantages.
ethods
tudy design and protocol. From April 2006 to November
007, a multicenter, prospective, nonrandomized registry
as conducted in 12 representative Japanese medical cen-
ers. All consecutive patients scheduled to undergo PCI for
CTO of a native coronary artery were considered for
nrollment, targeting a total of 500 patients. A CTO was
efined as an occlusion on angiography with no antegrade
lling of the distal vessel other than via collaterals. The
uration of the occlusion had to be more than 30 days,
stimated from onset of clinical events such as myocardial
nfarction (MI), sudden onset or worsening of the chest
bbreviations
nd Acronyms
IN  contrast-induced
ephropathy
TO  chronic total
cclusion
ES  drug-eluting stent(s)
GFR  estimated
lomerular filtration rate
W  guidewire
D  hemodialysis
I  myocardial infarction
LD  minimal lumen
iameter
CI  percutaneous
oronary intervention
CA  quantitative coronary
ngiographyymptoms, or proven by angiography. If the duration of the tcclusion was uncertain, but the investigators had no clear
eason to date the onset of the CTO at 30 days, the
atient was enrolled. Patients who met the following criteria
ere excluded: 1) bleeding diathesis or coagulation disorder;
) pregnancy; 3) severe allergy to iodinated contrast mate-
ial; and 4) Kawasaki’s disease or other vasculitis. All
rocedural and technical details and the choice of devices
nd anticoagulation regimens were according to the inves-
igator’s judgment. Antiplatelet agent regimens consisted of
spirin indefinitely and ticlopidine (200 mg daily, Japanese
tandard dose) or clopidogrel (75 mg daily) for at least 6
onths after the procedure for DES and at least 1 month
or bare-metal stents or balloon angioplasty. The study
rotocols were approved by the institutional review board at
ach participating center, and all patients provided written
nformed consent.
tudy end points and deﬁnitions. The end points evaluated
n this study included guidewire (GW) success rate (con-
rmed by an independent core laboratory), lesion success
ate (final % diameter stenosis 50% by quantitative coro-
ary angiography [QCA]), GW manipulation time (time
rom initial insertion of GW into the coronary lumen to
ime GW successfully crossing the lesion or GW being
ulled out of lumen because of GW failure), contrast
olume, fluoroscopic time, contrast-induced nephropathy
CIN) (defined as an absolute increase in serum creatinine
oncentration from the baseline value of at least 0.5 mg/dl
14]), radiation dermatitis (confirmed by dermatologists),
ngiographically documented coronary perforation, cardiac
eath, all-cause death, Q-wave MI or non–Q-wave MI
defined as post-procedural creatine kinase elevation 3
imes the normal value), stent thrombosis based on
cademic Research Consortium definition, target lesion
r vessel revascularization, stroke, and major adverse
ardiac events (i.e., death, MI, and target vessel revascu-
arization). Chronic kidney disease was defined as not
eing on maintenance hemodialysis (HD) and an esti-
ated glomerular filtration rate (eGFR) 30 ml/min/
.73 m2, calculated by the modification of diet in renal
isease formula (14).
ualitative coronary angiography and QCA. The angio-
rams of the target procedures were sent to an independent
ore angiographic laboratory at the Tokyo core analysis
aboratory located in Tokai University. Qualitative assess-
ent was performed by an expert physician who also usually
reated CTO lesions. Coronary perforation was defined as
ny contrast pool or evidence of contrast leak into cardiac
hambers or pericardial space. Perforations were divided
nto 2 categories by the location of perforation: 1) those in
he CTO artery, including CTO site, distal ends, and any
ortions throughout the CTO vessel; and 2) those within
he retrograde channels. QCA was performed by 2 trained
ngiographic technicians using the automated edge detec-
ion system (QCA-CMS version 6.0, Medis, Leiden, the
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145etherlands). Occlusion length was measured from the
roximal occlusion to the distal retrograde filling from
ontralateral collaterals using a dual injection technique,
tart of filling of bridging collaterals to distal vessel recon-
truction, or from the length of the lesion visible after the
W crossing. If stents were not used, minimal lumen
iameter (MLD) and reference diameter were measured. If
tents were implanted, in-stent and in-lesion segments were
ssessed.
tatistical analysis. Continuous variables were presented as
ean  SD or median and range if appropriate. Discrete
ariables were expressed as percentages. Chi-square test or
ischer exact test was used for categorical variables, and
npaired Student t test and Wilcoxon test were used for
ontinuous variables. A p value 0.05 was considered
tatistically significant. All statistical analyses were per-
ormed with JMP version 8.0 (SAS Institute, Cary, North
arolina).
esults
atients, lesions, and procedural characteristics. Between
pril 2006 and December 2007, a total of 498 patients with
Table 1. Baseline Patient Characteristics (n  498)
Age (yrs) 66.9 11.0
80 yrs old 59 (11.8)
Male sex 406 (81.5)
Symptom of angina/acute MI 351 (70.5)
Heart failure 88 (17.6)
Diabetes 216 (43.3)
Insulin required 63 (12.7)
Hypertension 367 (73.6)
Dyslipidemia on medication 276 (55.4)
eGFR 30 ml/min/1.73 m2 32 (6.4)
Without hemodialysis 11 (2.2)
With hemodialysis 21 (4.2)
History of CABG 48 (9.6)
History of stroke 9 (1.9)
Peripheral vascular disease 56 (11.2)
LV ejection function (%) 54.7 13.0%
Low LVEF (40%) 73 (14.7)
Number of diseased arteries
Triple vessel 113 (22.7)
Double vessel 163 (32.7)
Single vessel 174 (34.9)
History of CABG 48 (9.6)
History of MI 224 (44.9)
Unprotected LM disease 31 (6.2)
Prior PCI 236 (47.3)
Values are mean SD or n (%).
CABG coronary artery bypass grafting; eGFR estimated glomerular filtration rate; LM left
main; LV left ventricle; LVEF left ventricular ejection fraction; MImyocardial infarction; PCI
percutaneous coronary intervention.28 CTO lesions were enrolled in this study. Baselineatient characteristics are displayed in Table 1. Fifty-nine of
98 patients (11.8%) were 80 years old. The incidence of
revious history of heart failure was high (17.6%). Further-
ore, high incidences of diabetes (43.3%) and chronic HD
4.2%) were consistent with the report from another Japa-
ese interventional registry (15). The majority (55.4%) of
atients had multivessel disease. Baseline lesion character-
stics are listed in Table 2. Previous failed attempt of PCI
or the same CTO lesion had been undertaken in 10.2% of
he lesions. Incidence of the known predictors of CTO
ailure, including abrupt CTO entry, calcification, bridge
Table 2. Baseline Lesion and Procedural Characteristics
(n  528 Lesions)
Location of CTO
LAD 190 (36.0)
RCA 234 (44.3)
LCx 101 (19.1)
LM 3 (0.6)
In-stent restenosis 34 (6.4)
Previously failed (retry) lesion 54 (10.2)
Qualitative and quantitative coronary assessment
Side branches (within 3 mm from entry) 418 (79.2)
CTO entry type, abrupt 204 (38.6)
Calciﬁcation 290 (54.9)
Bridge collateral 118 (22.3)
Bending 45° 237 (44.9)
Rentrop grade III collateral 451 (85.4)
Occlusion length (mm) 13.5 13.0
Reference diameter (proximal only) (mm) 2.9 0.7
Approach site (antegrade route)
Femoral 463 (87.6)
Brachial 21 (4.0)
Radial 44 (8.4)
Sheath size
6-F 54 (10.2)
7-F 433 (82.0)
8-F 39 (7.4)
Contralateral injection 370 (70.1)
A total number of used GWs 4 (1–10)
Dilation strategies (lesion success case only, n  457)
Stent use 445 (97.3)
Drug-eluting stent use 432 (94.5)
Bare-metal stent use 65 (14.2)
POBA 12 (2.6)
Stent length by QCA (mm) 48.6 24.6
Contrast volume
Total volume (ml) 293 (53–1,097)
CTO procedure completion (ml) 251 (20–1,030)
GW cross (ml) 148 (4–900)
Total ﬂuoroscopic time (min) 45 (1–301)
Values are n (%), mean SD, or median (range).
CTO chronic total occlusion; GW guidewire; LAD left anterior descending artery; LCx
left circumflex artery; LM left main; POBA plain old balloon angioplasty; QCA quantitativecoronary angiography; RCA right coronary artery.
c
a
T
w
t
w
m
w
u
i
p
a
c
0
m
2
G
c
t
r
i
fi
r
a
R
d
g
m
r
p
t
r
o
r
tal oc
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 2 , 2 0 1 0
F E B R U A R Y 2 0 1 0 : 1 4 3 – 5 1
Morino et al.
In-Hospital Outcomes of the J-CTO Registry
146ollateral, bending, Rentrop grading, and occlusion length
re summarized in Table 2.
The procedural characteristics are also presented in Table 2.
he median number of GWs used during the procedures
as 4.0 (range 1 to 10). Figure 1 illustrates a flow chart of
he selected GW strategies. Almost one-half of the lesions
ere treated with single wiring, and the rest were done with
ultiple wiring techniques. An initial retrograde approach
as attempted in 14.6% of PCIs for CTOs. Stents were
sed in the majority (97.3%) of lesions if vessel size allowed
t, and a DES was selected in 94.5% of lesions. In the
rocedural success subgroup, in-lesion reference diameter
nd MLD were significantly smaller in the nonstented cases
ompared with the stented cases at post-treatment (2.04 
.53 mm vs. 2.41  0.59 mm, p  0.001 and 1.26  0.54
m vs. 1.57  0.49 mm, p  0.001). In-stent MLD was
.21  0.40 mm.
W and lesion success rate. Overall GW and lesion suc-
ess rates were extremely high (87.7% and 86.6%, respec-
ively) (Fig. 2). Among these, the success rates of the
etry cases (previously attempted but failed) were signif-
cantly lower (72.2% and 68.5%), compared with those of
rst attempt cases (89.5% and 88.6%). Lesion success
ates according to each category of selected GW strategy
re shown in Figure 1.
etrograde approaches and success rate. Table 3 displays a
etailed assessment of the subgroup treated with the retro-
Figure 1. Schematic Representation (Flow Chart) of Selected GW Strategi
Lesion success rate was calculated in each strategy category. CTO  chronic torade approach (n  136, 25.7% of the procedures). In theajority of cases (79.4%) with a retrograde approach,
etrograde wiring was started at the very early stage of the
rocedures. Lesion success rate of the “retrograde first
ouch” subsets was overall relatively high (79.2%) among the
etrograde approach cases. If the retrograde wire crossed
ver the collateral channel and successfully reached the
e-entry side of CTO segments (74.5% of the retrograde
PCI of CTOs (n  528 Lesions)
clusion; GW  guidewire; PCI  percutaneous coronary intervention.
Figure 2. GW Success and Lesion Success Rate (n  528)
Retry means attempt for previously failed chronic total occlusion lesions.
GW  guidewire.es for
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147ttempts), final lesion success rate of this subset was remark-
bly high (93.9%). All success cases were finalized with
ntegrade stent and/or balloon delivery.
W manipulation time and success rate. Distribution of
W manipulation time is shown in Figure 3A. Nearly
ne-half of the cases were completed within 30 min.
pproximately 10% of the procedures took more than 2 h.
W manipulation time was significantly longer in the
ailure cases compared with the success cases (median 85
in vs. 26 min, respectively; p  0.0001). The GW success
ate of each time category is displayed in Figure 3B. Of
ote, GW success rate decreased nearly time-dependently.
he cases that required GW manipulation time of60 min
chieved a high GW success rate (93.3%). However, the
Figure 3. Frequency Distribution of GW Manipulation Time and Correspond
Frequency distribution of guidewire (GW) manipulation time (A) and GW succe
Table 3. Detailed Assessment of Retrograde Approach (n  136)
Incidence
Lesion
Success Rate
Timings of retrograde wiring
Retrograde earlier than antegrade 77 (56.6) 79.2
After quick antegrade wiring 31 (22.8) 74.2
After sufﬁcient antegrade wiring 28 (20.6) 67.9
Used retrograde route
Septal route 87 (63.9) 86.7
Epicardial route 27 (20.2) 78.3
Graft route 21 (15.1) 72.2
Self artery route (bridging collateral) 1 (0.84) 100.0
Advancement of retrograde wire
Crossed channel, reached re-entry of CTO 101 (74.5) 93.9
Crossed channel, but not reached re-entry 4 (2.73) 33.3
Channels not crossed 31 (22.7) 60.0
Values are n (%) or %.
Abbreviations as in Table 2.were completed in 30 min. A signiﬁcant difference was observed between success anduccess rate decreased to 49.9% for those requiring more
han 120 min.
n-hospital complications. Table 4 summarizes complica-
ions and in-hospital outcomes. Cardiac death was seen only
n 0.2% of cases. Post-procedure creatine phosphokinase
as followed in 420 patients (84.4%). Among them, 10
atients satisfied the definition of MI, exceeding 3 times the
ormal value of creatine phosphokinase. Only 1 case
howed Q-wave MI (0.24%), and the other 9 cases were
dentified as non–Q-wave MI (2.1%) with clinical symp-
oms in only 1 patient. There was no stroke or stent
hrombosis during hospital stay. Significant in-hospital
omplications, including cardiac tamponade, emergent re-
Success Rate
e inversely related to GW manipulation time (B). Nearly one-half of the cases
Table 4. Complications and In-Hospital Outcomes
Complications
Cardiac tamponade 2 (0.4)
Emergent PCI 2 (0.4)
Emergent CABG 0 (0)
Blood transfusion 8 (1.6)
Access site surgery 2 (0.4)
Gastrointestinal bleeding 1 (0.2)
Contrast-induced nephropathy 6 (1.2)
Radiation dermatitis 0 (0)
In-hospital adverse outcomes
All-cause death 2 (0.4)
Cardiac death 1 (0.2)
Q-wave myocardial infarction 1 (0.2)
Non–Q-wave myocardial infarction 10 (2.1)
Stroke 0 (0)
Stent thrombosis 0 (0)
Values are n (%).
Abbreviations as in Table 1.ing GW
ss rat
failure cases. GW success rate inversely related to GW manipulation time.
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148ascularization, access site surgery, and gastrointestinal
leeding, rarely occurred.
luoroscopic time and contrast volume. Distribution of flu-
roscopic time for procedural success and failure is displayed
n Figure 4. Similar to GW manipulation time, fluoroscopic
imes were longer in the failure cases than the success cases
median 60 min vs. 41 min, p  0.001). Despite relatively
ong fluoroscopic time, none of the cases in this cohort
eveloped radiation dermatitis during the hospital stay
Table 4).
The median of contrast volume required for GW crossing
as 148 ml (GW success cases only); this was 251 ml for
TO procedure completion (lesion success cases only) and
93 ml used in total for all procedures including the failed
ases (Table 2). Interestingly, in contrast to GW manipu-
ation time and fluoroscopic time, contrast volume was not
tatistically significantly different between GW success cases
nd failures (median 285 ml vs. 330 ml, p  0.22) (Fig. 5).
xcept maintenance HD patients, serial serum creatinine
evels could be assessed in 408 patients (85.6%). Despite the
se of a relatively large contrast volume, the incidence of
IN was unexpectedly low (1.2%) in the non-HD patients.
here was no statistically significant difference in total
ontrast volume between the 2 groups of patients with or
ithout post-operative CIN (median 290 ml vs. 307 ml,
espectively; p  0.49). Importantly, pre-procedural serum
reatinine level and eGFR was almost identical between the
groups (mean  SD: 0.91  0.10 mg/dl vs. 0.93  0.32
g/dl, p  0.66 and 64.3 7.8 ml/min/1.73 m2 vs. 64.9 
7.8 ml/min/1.73 m2, p  0.69). All the patients with CIN
ad normal pre-procedural creatinine and eGFR levels.
oronary perforation. By a detailed qualitative assessment
f coronary angiography, angiographic coronary perforation
as detected in 7.2% (36 of 528) of the cases at the side of
Figure 4. Frequency Distribution of Total Fluoroscopic Time Comparing
Procedural Success and Failure
Overall, relatively long ﬂuoroscopic time was required for success in the
procedures. A signiﬁcant difference was observed in the ﬂuoroscopic timea
between success and failure cases.he CTO artery. All perforations occurred during GW
anipulation. Interestingly, perforations were more fre-
uent in procedures with a retrograde approach (retrograde
hannels perforation 13.6% [17 of 127]; compared with the
TO artery; p  0.001). Table 5 summarizes specific types
f perforation sites and the additional treatment applied for
emostasis. The majority of perforations observed in the
TO artery were detected by contrast staining on angio-
ram (99.8%), only 0.2% showed blow-out perforation. In
ontrast, retrograde channel perforation was associated with
requent perforations into cardiac spaces (41.2%), in addi-
ion to contrast staining (58.8%). No action was taken in
ore than 70% of angiographic perforations, and they did
ot present significant clinical problems. One-third of
atients with angiographic perforation required hemostatic
rocedures. Pericardiocentesis was required only in 2 cases
f perforations in the CTO artery (0.2% of the procedures,
.8% of the perforations); 1 was a blow-out perforation and
he other was contrast staining type; both occurred during
ntegrade GW manipulation. None of the cases with
etrograde channel perforation had cardiac tamponade.
ven when coronary perforation was detected angiographi-
ally during the procedures, final GW success was achieved
n 71.7% of patients.
iscussion
enerally, low initial success rate remains to be the biggest
ssue regarding PCI for CTO. Data from 25 years of
xperience from the Mayo Clinic indicate that although the
nitial success rate of PCI of CTO improved from 51% in
he balloon angioplasty era to 72% in the early stent era, it
eached a plateau of about 72% in the bare-metal stent era
Figure 5. Frequency Distribution of Total Contrast Volume Used During
the Procedures
There was no statistically signiﬁcant difference in contrast volume between
success and failure cases. Abbreviations as in Figure 1.nd 70% in the DES era (2). Other reports indicate that the
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149ate remains around the high 60% to mid-70% across the
tudies (1,5,6). Contrary to the expectations, adverse event
ates relating to PCI of CTO were found to be comparable to
hose of PCI for non-CTO lesions (5). However, more
omplex and aggressive strategies may possibly increase the
dverse event rate, which remains to be addressed. In the
-CTO registry, the data demonstrated outstanding out-
omes, including one of the highest procedural success rates
nd the lowest substantial complication rates among the
ublished reports ever.
istorical comparisons and potential beneﬁts of the retro-
rade approach. Almost 3 years before the J-CTO registry,
he CONQUEST (CTO New techniQUE for STandard
rocedure) registry was conducted by the CTO “specialized”
perators at 6 Japanese centers (16). At that time, the
arallel wire technique, characterized as manipulation of 2
ires in a back-and-forth sequence until either wire reached
he distal exit point of the true lumen, was the last resort.
fter completion of the CONQUEST registry, a novel
W strategy, the “retrograde approach,” was proposed (17);
his technique had already been available during the enroll-
ent period of the J-CTO registry.
Interestingly, the proportion of CTO lesions requiring
ultiple wire strategies were almost identical between the 2
tudies (the CONQUEST registry 43.1% vs. the J-CTO
egistry 44.5%). Considering the increase in the number of
he participating operators in the J-CTO registry, the same
evel of high initial procedural success rate of de novo CTO
esions (the CONQUEST registry 86.2% vs. the J-CTO
egistry 86.6%) and reduction of contrast volume for target
reatment completion (the CONQUEST registry 339 
40 ml vs. the J-CTO registry 274  151 ml) is quite
eaningful. Reduction of contrast volume might be primar-
ly due to the retrograde GW that plays a role as a “marker”
f the distal true lumen. Furthermore, excellent contralat-
ral imaging could be obtained by injecting very small
mounts of contrast super-selectively from the collateral
Table 5. Severity of Angiographic Coronary Perforation and Hemostatic Tre
Perforation in the CTO Artery (n  36)
Severity Actions n (%)
Contrast staining
n  35 (99.8%)
Observation 25 (71.4%)
Hemostatic procedures 10 (28.6%)
Self-fat emboli 4
Ballooning 3
Balloon  drainage 1
Others 2
Perforation into pericardial space
n  1 (0.2%)
Observation 0 (0%)
Hemostatic procedure 1 (100%)
Coiling  drainage 1
Abbreviations as in Table 2.hannel using a micro-catheter. tThe most desirable feature of the retrograde approach is
hat it engages the distal true lumen, which is the target
oint of the antegrade wire. Once retrograde GW success-
ully passes the collateral channels, the next step is to bring
he antegrade and retrograde GWs to meet somewhere in
he middle. In fact, we had an extremely high success rate of
3.9% in this registry, once such a face-to-face GW
ositioning was accomplished. Suitable case selection for
he retrograde approach remains to be defined.
isadvantages of PCI for CTO and its clinical impact. Poten-
ial disadvantages of CTO treatment include: 1) longer
rocedural and fluoroscopic times; 2) greater contrast vol-
me; and 3) high incidence of coronary perforation. In this
egistry, we had a consensus to minimize radiation exposure
omplications by frequently changing fluoroscopic projec-
ion angles during the procedures. Although specific data
re not available, such careful attention might possibly have
educed skin complications. A previous study has shown
hat limiting the total fluoroscopic time or dose area
roduct, or changing the beam angulations is important for
ontrolling the entrance skin dose during prolonged proce-
ures (18). Although no case developed radiation dermatitis
uring the hospital stay, prolonged careful evaluations
hould be performed to detect delayed skin problems.
CIN is one of the most serious issues of complex PCI.
ince investigators tried to adjust contrast volume based on
re-operative renal function, the incidence of CIN could be
inimized to 1.2% in this study. As a consequence, CIN
ccurred somewhat more frequently in the patients with
ormal creatinine levels; however, the actual contrast vol-
me used for these patients was not greater than average.
herefore, it may be difficult to anticipate complication of
IN in the pre-operative periods for the contrast volume
ange of this study. However, continuous efforts should be
ade to further decrease contrast volume for PCI of CTO.
Angiographic coronary perforation was frequently ob-
erved during CTO treatment; however, the most impor-
t
Perforation in Retrograde Channel (n  17)
Severity Actions n (%)
ontrast staining
n  10 (58.8%)
Observation 9 (90.0%)
Hemostatic procedure 1 (10.0%)
Ballooning 1
rforation into cardiac chambers
n  7 (41.2%)
Observation 6 (85.7%)
Hemostatic procedure 1 (14.3%)
Ballooning  coiling 1
rforation into pericardial space
n  0 (0%)
NA NAatmen
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150ardiac tamponade or not. In this registry “clinical perfora-
ion” requiring any hemostatic maneuvers occurred in less
han 30% of the cases with angiographic perforation. Eval-
ating the clinical significance of angiographic perforation is
ritically important, and our goal must be to avoid cardiac
amponade. The incidence of cardiac tamponade in the
-CTO registry was strikingly low at 0.4%, compared with
he previous reports (a range of 0.8% to 1.9%) (2,16).
otential hypotheses to explain the decreased incidence of
ardiac tamponade in the J-CTO registry are: 1) adequate
emostatic procedures as needed; and 2) reduction of long
nd aggressive antegrade GW manipulation, thanks to the
ntroduction of retrograde approaches. A surprising finding
as that relatively high procedural success rate was achieved
ven after angiographic detection of coronary perforation.
lthough a careful evaluation is required, procedural con-
inuation could be considered for many cases with angio-
raphic coronary perforation.
new paradigm for CTO treatment. In general, PCI proce-
ures for CTO lesions are not always difficult for the
ollowing reasons: 1) nearly one-half of the cases were
uccessfully treated with single, antegrade wiring and with
W manipulation time of 30 min, as we observed in this
egistry; and 2) “true” occlusion length tends to be shorter
han we could determine from unilateral diagnostic angiog-
aphy. In the J-CTO registry, mean occlusion length was
elatively short as evaluated by frequent use of guiding
atheters for contralateral injection allowing excellent col-
ateral images.
Although the majority of CTO studies indicated initial
uccess rates of approximately 70% (1,2,5,6), we believe that
his can be improved up to 80% or 90% by introduction of
djunctive GW strategies as shown in this trial and the
ONQUEST trial (16). Our study demonstrated that the
linical impacts of the disadvantages of PCI of CTO on
rgan damage were fairly small. Furthermore, the efficacy of
ES ensures long-term patency of recanalized CTO lesions
11–13). Therefore, it might be possible to consider a
PCI-first strategy for CTO lesions.” Further investigation
ocusing on long-term results as compared with coronary
rtery bypass grafting surgery would be required to justify
he proposed new paradigm for CTO treatment.
tudy limitations. Potential limitations of this study should
e considered. First, lack of randomization design did not
llow any type of comparisons in this study. Second, the
perators participating in this registry were limited in the
nly advanced PCI centers. In general, the outcomes are
ependent on basic skills and judgments of the physicians
erforming the procedures. There must be clear differences
etween “experienced” operators in the J-CTO registry and
ess experienced PCI operators. However, continuous efforts
nd adequate training must fill these technical and/or
udgment gaps. Third, some cases with procedural success
ere finally achieved by the operators’ persistent “efforts.” mxcept procedural time, we did not perform any assessments
f quantification of these factors, which might cause a bias
n the results. Fourth, although this trial was designed to
nroll consecutive series of CTO lesions treated in each
articipating site, there was no means to confirm whether
onsecutive cases were truly registered in this trial. Further-
ore, actual PCI attempt rate among the all CTO lesions
ould not be addressed, because of lack of the exact numbers
f the CTO cases that: 1) were sent to bypass surgery; or
) were followed medically during the study periods. Fifth,
ecause not all patients received post-procedural blood tests
approximately 85% of the enrolled population had mea-
urements), accurate incidence of CIN or MI could not be
ssessed. However, since post-procedural blood tests tend to
e performed in high-risk patients or in patients with
eriprocedural problems, the true incidence might not
xceed the actual data obtained. Sixth, since radiation
ermatitis is most often detected after several weeks, the
valuation period appeared to be insufficient. Although no
pecific skin problems were additionally reported from the
articipating sites, conclusive confirmation must be ob-
ained. Finally, in this registry, an occlusion duration of30
ays was used as the definition of CTO, consistent with the
revious reports (11,19). Recently, CTO has been com-
only defined as 3 months of occlusion duration after
everal consensus reports (2,7,20). The study protocol was
lready established before these consensus reports were
ublished. We estimated that a very few cases had occlusion
uration of3 months, which is unlikely to have influenced
he overall success rates.
onclusions
n-hospital analysis of the J-CTO registry showed a high
rocedural success rate in the real-world consecutive series
f patients using complex wiring strategies. This was
chieved at the expense of longer fluoroscopy time, a larger
olume of contrast material, and elevated risks of coronary
erforation; however, such procedural characteristics were
ot commonly associated with serious clinical sequelae.
verall, the incidence of major cardiac adverse events was
ery low, comparable to that of general interventional
reatments. Invasiveness and potential risks of these aggres-
ive strategies, which have constituted the greatest concerns
f CTO treatment, might be acceptable considering the
ctual incidences of related adverse events and the proce-
ural success rates.
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